Colgate-Palmolive (CL) Rated Outperform by RBC as Long-Term Growth Remains in Focus

Colgate-Palmolive Company (NYSE:CL) is included among the 15 Best Stocks to Buy for the Long Term.

On December 9, RBC Capital raised its rating on Colgate-Palmolive Company (NYSE:CL) to Outperform from Sector Perform while keeping the price target at $88. The analyst noted that the stock has been under pressure recently as slower global category growth has weighed on expectations for the company. Even so, the firm thinks 2026 will still be a challenging year, but believes estimates and expectations are “appropriately low.” RBC sees the setup as encouraging as Colgate works its way back toward its long-term growth goals.

In its earnings call for the third quarter of 2025, CEO Noel Wallace highlighted a volatile operating backdrop due to ongoing consumer uncertainty, tariffs, geopolitical issues, high cost inflation, and several other headwinds that have been affecting sales and profitability across the industry. Despite these challenges, he emphasized the company’s commitment to its 2030 Strategy. He also noted that Colgate-Palmolive Company (NYSE:CL) has healthy brands in categories that continue to grow, strong market share, a wide global presence with nearly half of its business coming from faster-growing emerging markets, and a highly efficient global supply chain to support that demand.

Colgate-Palmolive Company (NYSE:CL) updated its organic sales growth outlook to be roughly in line with the results so far this year, which suggests growth of around 1.2% for 2025. The figure also includes a 70 basis point hit from the company’s exit from private label. In addition, Colgate is a reliable dividend payer and has increased its dividends for 62 straight years.

Colgate-Palmolive Company (NYSE:CL) is a major American multinational consumer products company and a trusted leader in household and personal care goods.

READ NEXT: 15 Dividend Stocks Paying 4%+ Yield in 2025 and 11 Worst Performing Dividend Stocks Year-to-Date.

Disclosure: None.